Foresight Health® Malignant Hyperthermia


Our Foresight Health® single test for Malignant Hyperthermia is ideal for breeders and owners who want the reassurance of genetic health testing.

The guideline turnaround time for single tests is approximately 10-12 working days after the swab arrives at the lab. 

If you need more than two tests it is often more cost-effective to order the relevant Foresight Health® breed package.


Malignant Hyperthermia (MH) is a reaction whilst under general anaesthesia which causes a progressive increase in body temperature, increased heart rate, renal failure, and death.

An autosomal dominant condition caused by a mutation in the RYR1 gene.


This test is also included in the following Foresight Health® breed packages:


Scientific references:

Roberts MC, Mickelson JR, Patterson EE, Nelson TE, Armstrong PJ, Brunson DB, Hogan K. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1). Anesthesiology. 2001 Sep;95(3):716-25

You recently viewed

Clear recently viewed